secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2023-04-26T23:59:59+00:00
Accession:  0001104659-23-050338
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences raises $2.5M via registered direct offering and private placement at $3.07/unit
--------------------------------------------------------------------------------

- Entered into securities purchase agreement with institutional investor for 800,695 shares/pre-funded warrants at $3.07/unit, raising ~$2.5M gross.
- Concurrent private placement of warrants to purchase 800,695 shares at $3.07, exercisable immediately, expire in 5.5 years.
- Amended existing warrants for 164,656 shares from $15.00 to $3.07 exercise price effective upon closing.
- Placement agent Maxim Group receives 7% cash fee and 40,035 warrants at $3.38 exercise price.
- Offering expected to close on or about April 24, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000110465923050338/0001104659-23-050338-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000110465923050338/tm2313709d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-050338

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer